Crown Bioscience Blog (27)

close

February 17, 2025

Crown Bioscience Completes Merger with Indivumed Services

February 11, 2025

Crown Bioscience Germany GmbH Achieves Continued CAP 15189:2022 Accreditation

December 11, 2024

Crown Bioscience Wins 2024 Fierce CRO Award for Excellence in Client Service and Partnership

December 10, 2024

Crown Bioscience Wins BioTech Breakthrough Award for Drug Development Innovation

December 12, 2024

Translating In Vitro and In Vivo Multi-Omics Oncology Data to Enhance Early Biomarker Discovery

October 30, 2024

Prostate Cancer Breakthrough: Crown Bioscience Collaborates in €1.75M Eurostars Funded Project for Novel Liquid Biopsy Test

October 1, 2024

Crown Bioscience Expands Singapore Facility with Advanced Oncology Models and Imaging Capabilities

August 21, 2024

Crown Bioscience Partners with CTI to Support Consulting Services in Oncology Drug Development

May 24, 2024

Crown Bioscience Enters Global Agreement with Shanghai Model Organisms Center

May 23, 2024

Innovation Funding and Crown Bioscience: Collaborating to Discover the Next Wave of Oncology Therapies

Contact Us
Biospecimen Request
Databases
CrownLink

US Tel: +1 858 622 2900

UK Tel: +44 870 242 2900

All Contact Information

Our Services
Our Science
About Us
Contact us

Blog

Overcoming the Tumor Microenvironment and Heterogeneity to Improve Preclinical Response

3 minute read

Overcoming the Tumor Microenvironment and Heterogeneity to Improve Preclinical Response

July 20, 2017

How to Use PDX in Immuno-Oncology Studies

2 minute read

How to Use PDX in Immuno-Oncology Studies

July 18, 2017

Oncolytic Viruses: From History to Where We Go Next

3 minute read

Oncolytic Viruses: From History to Where We Go Next

July 11, 2017

Breast Cancer PDX Models

2 minute read

Breast Cancer PDX Models

June 13, 2017

First Cancer Drug Approval Based on Biomarkers, not Tumor Location

2 minute read

First Cancer Drug Approval Based on Biomarkers, not Tumor Location

June 8, 2017

How to Choose Patient-Derived Xenograft (PDX) Models

2 minute read

How to Choose Patient-Derived Xenograft (PDX) Models

May 30, 2017

Preclinical Immuno-Oncology Models 101

3 minute read

Preclinical Immuno-Oncology Models 101

May 25, 2017

When to Use Conventional Cell Line Derived Xenograft Models

2 minute read

When to Use Conventional Cell Line Derived Xenograft Models

May 23, 2017

When to add Patient-Derived Xenografts (PDX) to Preclinical Drug Development Programs

2 minute read

When to add Patient-Derived Xenografts (PDX) to Preclinical Drug Development Programs

May 12, 2017

The Beginners Guide to Patient-Derived Xenograft (PDX) Models

3 minute read

The Beginners Guide to Patient-Derived Xenograft (PDX) Models

May 9, 2017

View Recent Posts View Older Posts

Search our Blog

Categories

About Us

Our Company
Our Purpose
Our Responsibility
Leadership
News & Events

Our Services

Platforms
Target Solutions
Technologies
Service Type

Resources

Blog
Preclinical Models
Publications
Factsheets
White Papers
Ebooks
Webinars

Platforms

OncoExpress™
XenoBase®
MuBase®
HuBase™
OrganoidBase™
CrownLink™

Talk To Us

+1 858 381 3547
Contact Us
Distributors
LinkedIn
X

© 2025 Crown Bioscience. All Rights Reserved.

Privacy Policy | Imprint | Terms of Service | Privacy Preferences

© 2025 Crown Bioscience. All Rights Reserved. Privacy Policy

2024-05-23

2022-12-16